Evidence map›Paper›PMID 24311119›Full record

ReviewJournal of molecular medicine (Berlin, Germany)2014

Metastasis suppressors in breast cancers: mechanistic insights and clinical potential.

Christopher R Bohl, Sitaram Harihar, Warren L Denning, Rahul Sharma, Danny R Welch

Abstract readReview
In one paragraph

Review in Journal of molecular medicine (Berlin, Germany), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. MicroRNAs as therapeutic targets in breast cancer metastasis.Drug delivery and translational research · 2022
    Review
  5. Is ThereCancers · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. International journal of molecular sciences · 2020
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. A survey of metastasis suppressors in Metazoa.Laboratory investigation; a journal of technical methods and pathology · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. EngineeredJournal of biological engineering · 2018
    Review
  19. Inhibition of cancer cell migration with CuS@ mSiOInternational journal of nanomedicine · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Christopher R Bohl *Department of Cancer Biology The University of Kansas Medical Center, Kansas City, KS 66160, USA.
Sitaram Harihar *Department of Cancer Biology The University of Kansas Medical Center, Kansas City, KS 66160, USA.
Warren L Denning *Department of Cancer Biology The University of Kansas Medical Center, Kansas City, KS 66160, USA.
Rahul SharmaDepartment of Cancer Biology The University of Kansas Medical Center, Kansas City, KS 66160, USA.
Danny R WelchDepartment of Cancer Biology The University of Kansas Medical Center, Kansas City, KS 66160, USA.

Funding

Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NICOLE L NOLLEN · 2012 to 2026
$40.1M
MOLECULAR REGULATION OF BREAST CANCER METASTASISR01CA087728 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WELCH, DANNY R. · 2000 to 2008
$2.7M
KISS1: Defining Mechanisms for Antimetastatic TherapyR01CA134981 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI WELCH, DANNY R. · 2009 to 2014
$1.5M
NCI NIH HHS P30 CA168524NCI NIH HHS P30-CA168524NCI NIH HHS R01 CA087728NCI NIH HHS R01 CA134981NCI NIH HHS R01-CA134981NCI NIH HHS R01-CA87728
6 · The paper itself

Abstract

For the most part, normal epithelial cells do not disseminate to other parts of the body and proliferate, as do metastatic cells. Presumably, a class of molecules-termed metastasis suppressors-are involved in this homeostatic control. Metastasis suppressors are, by definition, cellular factors that, when re-expressed in metastatic cells, functionally inhibit metastasis without significantly inhibiting tumor growth. In this brief review, we catalog known metastasis suppressors, what is known about their mechanism(s) of action, and experimental and clinical associations to date.

Indexed as

AnimalsBreast NeoplasmsFemaleHumansNeoplasm MetastasisSignal TransductionTumor Suppressor ProteinsTumor Suppressor Proteins

Identifiers

PMID24311119
PMCPMC3923422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.